KUALA LUMPUR -- A ban on Top Glove-manufactured products in the U.S. contributed to double-digit declines in revenue and net profit in the three months ended May 31 from the previous quarter, the Malaysian medical glove maker announced on Wednesday.
Revenue and net profit fell 22% and 29%, respectively to 4.16 billion ringgit ($1 billion) and 2.06 billion ringgit in the financial third quarter from the second, the company said in a stock market filing.
